---
$id: https://graph.org.ai/products/commodity/51112015
$type: Product
source: UNSPSC
code: "51112015"
title: "Imatinib mesiate or mesylate"
class: "51112000"
classTitle: "Tyrosine kinase inhibitors"
family: "51110000"
familyTitle: "Antineoplastic agents"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Imatinib mesiate or mesylate

**UNSPSC Code**: 51112015
**Class**: [Tyrosine kinase inhibitors](Tyrosine kinase inhibitors.mdx)
**Family**: [Antineoplastic agents](../Antineoplastic agents.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes a tyrosine kinase inhibitor with the molecular formula C29H31N7O.CH4O3S, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 8A1O1M485B, chemically known as benzamide, 4-((4-methyl-1-piperazinyl)methyl)-n-(4-methyl-3-((4-(3-pyridinyl)-2-pyrimidinyl)aminophenyl)-, methanesulfonate salt, but more generally known as imatinib mesylate, which bears US NIH Compound Identifier 5291. European Medicines Agency schedules imatinib mesylate or its base in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB25387. As of Q4 2014, IMATINIB MESYLATE remains US FDA's Preferred Term for this commodity. Imatinib mesylate bears US NLM identifiers UMLS ID C0939537 and NCI Concept Code C1687. Most nations, for tariff purposes, schedule imatinib mesylate under HS 29335995. SMILES: CC1CCC(CC1NC2NCCC(N2)C3CCCNC3)NC(=O)C4CCC(CC4)CN5CCN(CC5)C.CS(=O)(=O)O.

